Compugen Ltd.

CGEN Stock Healthcare Biotechnology
$2.60
-0.16 (-5.80%)
Price as of Aug 28, 2026 market close

Performance

1 Month
+11.3%
3 Months
-1.1%
YTD
+69.9%
1 Year
+76.9%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
70.4%
Largest decline max drawdown, since Aug 2025
-36.8%
Risk-adjusted return Sharpe ratio, 1-year
1.15

Own CGEN?

See how CGEN contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.